Bhatt Elizabeth — SEC Form 4 filings
SEC reporting owner CIK 1748622. 8 Form 4 filings on record with FilingPulse; latest filed 2026-08-13.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-21 to 2026-08-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 37,000 shares, $1,449,178 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 25,000 shares @ $44.00 ($1,100,000) in Septerna, Inc., filed 2026-08-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Septerna, Inc. (SEPN) | President and COO | 6 | — | 7 legs · 37,000 sh · $1,449,178 | 12 |
| eFFECTOR Therapeutics, Inc. (EFTR) | Director | 2 | — | — | 2 |
Form 4 filings — Bhatt Elizabeth
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Septerna, Inc. (SEPN) | Option exercise (M): 18,681 @ $6.81 · Option exercise (M): 6,319 @ $2.76 · Sale (S): 25,000 @ $44 · Option exercise (M): 18,681 (derivative) @ $0 · Option exercise (M): 6,319 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | Septerna, Inc. (SEPN) | Option exercise (M): 4,000 @ $6.81 · Sale (S): 4,000 @ $33.99 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | Septerna, Inc. (SEPN) | Option exercise (M): 4,000 @ $6.81 · Sale (S): 2,573 @ $23.76 · Sale (S): 1,101 @ $25.24 · Sale (S): 326 @ $25.86 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Septerna, Inc. (SEPN) | Option exercise (M): 4,000 @ $6.81 · Sale (S): 2,200 @ $28.46 · Sale (S): 1,800 @ $29.58 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | Septerna, Inc. (SEPN) | Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Septerna, Inc. (SEPN) | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1748622 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →